Natural killer (NK) cells and killer (K) cells mediating antibody-dependent cellular cytotoxicity have been shown to be large granular lymphocytes (LGLs). Studies are proceeding to define the receptors and structures involved in NK recognition. Previously, a monoclonal antibody (MAb) was developed against NK target antigens on K562 cells and MAb blocked LGL binding and lysis. We also developed an anti-idiotypic antibody (anti-ID) against this MAb anticipating that it might recognize the NK receptor and aid in its identification. This anti-ID antibody is reactive with an effector cell protein and blocks LGLs binding and target cell lysis. Utilizing this anti-ID, an expression library from CD3- LGL was screened and specific cDNA clones were isolated. The cDNA coded for a unique 150 kDa protein that consisted of several distinct structural domains. The NH2-terminal domain was 50% homologous to cyclophilin, a cyclosporin binding protein. Based on the predicted amino acid sequence from this cDNA an anti-peptide (anti-p104) antisera was prepared to further examine the structure function relationship of this novel surface moiety involved in NK lytic function. The molecular and biochemical events involved in lymphocyte-mediated cytolysis are under extensive investigation. In particular, several cytoplasmic granule proteins of CTL and NK cells, including pore-forming protein (PFP, perforin or cytolysin) and serine esterases, have been extensively studied. PFP is the major cytolytic protein of the granules and represents an important structural component of the pore-formation and granule exocytosis models for lymphocyte-mediated cytotoxicity. Recently, we have examined the regulation of PFP mRNA in human peripheral blood T cells and LGL.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Intramural Research (Z01)
Project #
1Z01CM009247-11
Application #
3853289
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
11
Fiscal Year
1991
Total Cost
Indirect Cost
Name
Division of Cancer Treatment
Department
Type
DUNS #
City
State
Country
United States
Zip Code